Summary:
- This article discusses how Sophia Genetics, a company that uses artificial intelligence (AI) and digital twins, is transforming the field of oncology treatment.
- Digital twins are virtual models of a patient's tumor that can be used to test different treatment options and predict how the tumor will respond, allowing doctors to personalize and optimize treatment plans.
- By using AI and digital twins, Sophia Genetics aims to improve the accuracy and effectiveness of cancer treatments, ultimately leading to better outcomes for patients.